Apr 30, 2019 / 12:30PM GMT
Operator
Good day, ladies and gentlemen, and welcome to the NeoGenomics First Quarter 2019 Earnings Call. (Operator Instructions)
At this time, it is my pleasure to turn the floor over to your host for today, Mr. Doug VanOort. Sir, the floor is yours.
Douglas M. VanOort - NeoGenomics, Inc. - Chairman & CEO
Thank you, Jesse. Good morning. I'd like to welcome everyone to NeoGenomics First Quarter 2019 Conference Call. Joining me from our Fort Myers headquarters is Sharon Virag, our Chief Financial Officer; Rob Shovlin, President of our Clinical Services Division; and Bill Bonello, Chief Strategy and Corporate Development Officer and Director of Investor Relations. Joining us on the phone from Aliso Viejo is Dr. Larry Weiss, our Chief Scientific Officer.
Before we begin our prepared remarks, Bill Bonello will read the standard language about forward-looking statements.
William Bishop Bonello - NeoGenomics, Inc. - Chief Strategy & Corporate Development Officer and Director of IR
This conference call may
Q1 2019 Neogenomics Inc Earnings Call Transcript
Apr 30, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers